Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEKP POTEE POTEF POTEI	5.78e-06	11	235	4	GO:0098973
GeneOntologyMolecularFunction	tetrapyrrole binding	IDO1 JAK2 PXDN CYP26C1 DGCR8 CYP4V2 CYP26B1 TCN2 ADGB MTR	2.54e-05	164	235	10	GO:0046906
GeneOntologyMolecularFunction	glycerol channel activity	AQP7B AQP7P3 AQP7	5.44e-05	7	235	3	GO:0015254
GeneOntologyMolecularFunction	lipid transfer activity	ATG2A PITPNC1 APOA5 ESYT1 PITPNM1 PRELID3A	5.48e-05	57	235	6	GO:0120013
GeneOntologyMolecularFunction	glycerol transmembrane transporter activity	AQP7B AQP7P3 AQP7	1.28e-04	9	235	3	GO:0015168
GeneOntologyMolecularFunction	urea transmembrane transporter activity	AQP7B AQP7P3 AQP7	1.28e-04	9	235	3	GO:0015204
GeneOntologyMolecularFunction	glycosyltransferase activity	B3GALT4 TMTC2 PARP4 MGAT5 GALNT8 UGT8 GYG2 LARGE2 PIGV GCNT7 POFUT1 ZC3HAV1	1.66e-04	288	235	12	GO:0016757
GeneOntologyMolecularFunction	hexosyltransferase activity	B3GALT4 TMTC2 MGAT5 GALNT8 UGT8 GYG2 LARGE2 PIGV GCNT7 POFUT1	2.08e-04	211	235	10	GO:0016758
GeneOntologyMolecularFunction	phospholipid transfer activity	PITPNC1 ESYT1 PITPNM1 PRELID3A	2.28e-04	26	235	4	GO:0120014
GeneOntologyMolecularFunction	phospholipid transporter activity	PITPNC1 ABCA7 ESYT1 ANO10 PITPNM1 PRELID3A	2.37e-04	74	235	6	GO:0005548
GeneOntologyMolecularFunction	polyol transmembrane transporter activity	AQP7B AQP7P3 AQP7	4.22e-04	13	235	3	GO:0015166
GeneOntologyMolecularFunction	heme binding	IDO1 JAK2 PXDN CYP26C1 DGCR8 CYP4V2 CYP26B1 ADGB	4.88e-04	154	235	8	GO:0020037
GeneOntologyMolecularFunction	structural constituent of postsynapse	POTEKP POTEE POTEF POTEI	5.19e-04	32	235	4	GO:0099186
GeneOntologyMolecularFunction	lipid transporter activity	ATG2A PITPNC1 ABCA7 SLC27A2 APOA5 ESYT1 ANO10 PITPNM1 PRELID3A	5.41e-04	196	235	9	GO:0005319
GeneOntologyBiologicalProcess	T cell receptor V(D)J recombination	TCF7 BCL11B LEF1	1.44e-05	5	235	3	GO:0033153
GeneOntologyBiologicalProcess	somatic recombination of T cell receptor gene segments	TCF7 BCL11B LEF1	1.44e-05	5	235	3	GO:0002681
GeneOntologyBiologicalProcess	somatic diversification of T cell receptor genes	TCF7 BCL11B LEF1	1.44e-05	5	235	3	GO:0002568
GeneOntologyBiologicalProcess	intermembrane lipid transfer	ATG2A PITPNC1 ESYT1 PITPNM1 PRELID3A	3.91e-05	34	235	5	GO:0120009
GeneOntologyCellularComponent	microtubule associated complex	KATNAL2 HAUS6 DYNC1H1 DYNC1I1 DNAH3 FNTA DNAH10 ACTR1A DNAI2	1.15e-04	161	243	9	GO:0005875
GeneOntologyCellularComponent	dynein complex	DYNC1H1 DYNC1I1 DNAH3 DNAH10 DNAI2	4.05e-04	54	243	5	GO:0030286
GeneOntologyCellularComponent	beta-catenin-TCF complex	TCF7 TCF7L2 LEF1	4.07e-04	13	243	3	GO:1990907
GeneOntologyCellularComponent	lipid droplet	ATG2A AQP7P3 RNF213 AQP7 PITPNM1 LSS SMPD1	4.19e-04	116	243	7	GO:0005811
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEKP POTEE POTEF POTEI	4.96e-04	32	243	4	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEKP POTEE POTEF POTEI	4.96e-04	32	243	4	GO:0043189
Domain	NPIP	NPIPA1 NPIPB3 NPIPB5 NPIPB13 NPIPA5 NPIPA3 NPIPA7 NPIPB2	1.37e-12	14	231	8	IPR009443
Domain	DHR-1_domain	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	IPR027007
Domain	DHR_2	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	PS51651
Domain	DHR_1	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	PS51650
Domain	DHR-2	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	PF06920
Domain	DOCK	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	IPR026791
Domain	DOCK_C	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	IPR010703
Domain	DOCK-C2	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	PF14429
Domain	DHR-2	DOCK4 DOCK5 DOCK10 DOCK7	7.03e-06	11	231	4	IPR027357
Domain	CTNNB1_binding	TCF7 TCF7L2 LEF1	7.40e-06	4	231	3	PF08347
Domain	TCF/LEF	TCF7 TCF7L2 LEF1	7.40e-06	4	231	3	IPR024940
Domain	CTNNB1-bd_N	TCF7 TCF7L2 LEF1	7.40e-06	4	231	3	IPR013558
Domain	Actin_CS	POTEE POTEF ACTR1A POTEI	3.69e-05	16	231	4	IPR004001
Domain	ACTINS_2	POTEE POTEF ACTR1A POTEI	4.78e-05	17	231	4	PS00432
Domain	Actin/actin-like_CS	POTEE POTEF ACTR1A POTEI	6.09e-05	18	231	4	IPR020902
Domain	ACTINS_ACT_LIKE	POTEE POTEF ACTR1A POTEI	7.64e-05	19	231	4	PS01132
Domain	ARM-type_fold	CUL7 DOCK5 PSME4 AP1G1 ANKAR TBCD IPO5 RANBP6 ZNFX1 ELMO3 MROH8 MROH1 MTOR NUP188	8.83e-05	339	231	14	IPR016024
Domain	FNIP_N_dom	FNIP1 FNIP2	1.52e-04	2	231	2	IPR028084
Domain	FNIP_mid_dom	FNIP1 FNIP2	1.52e-04	2	231	2	IPR028085
Domain	FNIP_C_dom	FNIP1 FNIP2	1.52e-04	2	231	2	IPR028086
Domain	FNIP_C	FNIP1 FNIP2	1.52e-04	2	231	2	PF14638
Domain	FNIP_M	FNIP1 FNIP2	1.52e-04	2	231	2	PF14637
Domain	FNIP_N	FNIP1 FNIP2	1.52e-04	2	231	2	PF14636
Domain	Factor_5/8	F5 F8	1.52e-04	2	231	2	IPR024715
Domain	FNIP_fam	FNIP1 FNIP2	1.52e-04	2	231	2	IPR026156
Domain	HEAT_REPEAT	PSME4 TBCD IPO5 RANBP6 MROH1 MTOR	2.27e-04	70	231	6	PS50077
Domain	AAA	KATNAL2 ABCA7 DYNC1H1 DNAH3 DNAH10 RNF213 ABCC9 FIGN	4.32e-04	144	231	8	SM00382
Domain	AAA+_ATPase	KATNAL2 ABCA7 DYNC1H1 DNAH3 DNAH10 RNF213 ABCC9 FIGN	4.32e-04	144	231	8	IPR003593
Domain	-	AOC1 AOC3	4.53e-04	3	231	2	2.70.98.20
Domain	Cu_amine_oxidase_N3	AOC1 AOC3	4.53e-04	3	231	2	IPR015802
Domain	Cu_amine_oxidase_N2	AOC1 AOC3	4.53e-04	3	231	2	IPR015800
Domain	COPPER_AMINE_OXID_1	AOC1 AOC3	4.53e-04	3	231	2	PS01164
Domain	COPPER_AMINE_OXID_2	AOC1 AOC3	4.53e-04	3	231	2	PS01165
Domain	Cu_amine_oxidN2	AOC1 AOC3	4.53e-04	3	231	2	PF02727
Domain	Cu_amine_oxidN3	AOC1 AOC3	4.53e-04	3	231	2	PF02728
Domain	Cu_amine_oxidase_N-reg	AOC1 AOC3	4.53e-04	3	231	2	IPR016182
Domain	Cu_amine_oxid	AOC1 AOC3	4.53e-04	3	231	2	PF01179
Domain	Cu_amine_oxidase_C	AOC1 AOC3	4.53e-04	3	231	2	IPR015798
Domain	Actin	POTEE POTEF ACTR1A POTEI	5.52e-04	31	231	4	IPR004000
Domain	Actin	POTEE POTEF ACTR1A POTEI	5.52e-04	31	231	4	PF00022
Domain	ACTIN	POTEE POTEF ACTR1A POTEI	5.52e-04	31	231	4	SM00268
Domain	ARM-like	CUL7 PSME4 AP1G1 ANKAR TBCD IPO5 DOCK10 RANBP6 ELMO3 MROH1 MTOR	5.63e-04	270	231	11	IPR011989
Domain	Dynein_heavy_chain_D4_dom	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	IPR024317
Domain	Dynein_HC_stalk	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	IPR024743
Domain	Dynein_heavy_dom-2	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	IPR013602
Domain	DHC_N2	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	IPR011704
Domain	MT	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	PF12777
Domain	AAA_8	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	PF12780
Domain	Ldl_recept_b	LRP5L EGF LRP4	6.15e-04	14	231	3	PF00058
Domain	LDLRB	LRP5L EGF LRP4	6.15e-04	14	231	3	PS51120
Domain	AAA_5	DYNC1H1 DNAH3 DNAH10	6.15e-04	14	231	3	PF07728
Domain	HEAT	TBCD IPO5 RANBP6 MROH1 MTOR	7.45e-04	58	231	5	IPR000357
Domain	DHC_fam	DYNC1H1 DNAH3 DNAH10	7.61e-04	15	231	3	IPR026983
Domain	Dynein_heavy	DYNC1H1 DNAH3 DNAH10	7.61e-04	15	231	3	PF03028
Domain	LY	LRP5L EGF LRP4	7.61e-04	15	231	3	SM00135
Domain	Dynein_heavy_dom	DYNC1H1 DNAH3 DNAH10	7.61e-04	15	231	3	IPR004273
Domain	LDLR_classB_rpt	LRP5L EGF LRP4	7.61e-04	15	231	3	IPR000033
Domain	Cu_amine_oxidase	AOC1 AOC3	8.99e-04	4	231	2	IPR000269
Domain	DOCK_N	DOCK4 DOCK5	1.49e-03	5	231	2	PF16172
Domain	DOCK_N	DOCK4 DOCK5	1.49e-03	5	231	2	IPR032376
Domain	Cu-oxidase_3	F5 F8	1.49e-03	5	231	2	IPR011707
Domain	IP_trans	PITPNC1 PITPNM1	1.49e-03	5	231	2	PF02121
Domain	Guanine_nucleotide-bd_bsu	GNB1 GNB2	1.49e-03	5	231	2	IPR016346
Domain	MULTICOPPER_OXIDASE1	F5 F8	1.49e-03	5	231	2	PS00079
Domain	Cu_oxidase_CS	F5 F8	1.49e-03	5	231	2	IPR033138
Domain	Cu-oxidase_3	F5 F8	1.49e-03	5	231	2	PF07732
Domain	-	CUL7 PSME4 AP1G1 ANKAR TBCD IPO5 RANBP6 MROH1 MTOR	1.83e-03	222	231	9	1.25.10.10
Domain	PI_transfer	PITPNC1 PITPNM1	2.21e-03	6	231	2	IPR001666
Domain	Cu_oxidase_Cu_BS	F5 F8	2.21e-03	6	231	2	IPR002355
Domain	DUF3398	DOCK10 DOCK7	2.21e-03	6	231	2	PF11878
Domain	DOCK_C/D_N	DOCK10 DOCK7	2.21e-03	6	231	2	IPR021816
Pathway	KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY	TCF7 TCF7L2 LEF1	3.98e-05	6	180	3	M47736
Pathway	REACTOME_RUNX3_REGULATES_WNT_SIGNALING	TCF7 TCF7L2 LEF1	3.98e-05	6	180	3	MM15542
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY	TCF7 TCF7L2 LEF1	6.90e-05	7	180	3	M47465
Pathway	WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING	TCF7 TCF7L2 FNTA LEF1 TOR1AIP1	1.00e-04	37	180	5	M39817
Pathway	KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY	TCF7 TCF7L2 LEF1	1.09e-04	8	180	3	M47413
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION	TCF7 TCF7L2 LEF1	1.09e-04	8	180	3	MM17229
Pathway	REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS	TCF7 TCF7L2 LEF1	1.09e-04	8	180	3	M27359
Pathway	REACTOME_RUNX3_REGULATES_WNT_SIGNALING	TCF7 TCF7L2 LEF1	1.09e-04	8	180	3	M27821
Pathway	REACTOME_REPRESSION_OF_WNT_TARGET_GENES	TCF7 TCF7L2 LEF1	2.30e-04	10	180	3	MM15156
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY	TCF7 TCF7L2 LEF1	2.30e-04	10	180	3	M47486
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EMC1 KIAA0319L TMTC2 ITGA7 ITGAV ABCA7 JAG2 LMF2 MGAT5 PXDN UGT8 ARHGAP21 LARGE2 FKRP ESYT1 TMEM161B RANBP6 RNF213 CPT1A LIFR MYOF EPHA2 GLCE LRP4 SCPEP1 SMPD1 CHID1 TYW1 POFUT1 TOR1AIP1 SLC29A1	8.90e-10	1201	250	31	35696571
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ANKMY1 ADGRV1 MAP3K12 DENND2B PCNX2 JAG2 DOCK5 JAK2 PHKB KLHL9 PXDN FAM168A SUPT6H ANKAR KLHL23 FNIP1 PLA2G6 TBCD CYP4V2 BEST1 TCF7L2 POLG ENC1 RNF213 CPT1A TSEN2 RBM5 STYXL1 LSS GREB1 FBXO21 ZC3HAV1	3.66e-08	1489	250	32	28611215
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ILF2 AOC1 CDS2 PHKB UBE2R2 PSME4 FAM168A AP1G1 CNOT2 ARHGAP21 LARGE2 POC1A POLG AHCTF1 ICA1 ENC1 ANGEL1 SLU7 CLDND1 TMEM39B ZSCAN21 TYW1 NUP188 SLC29A1	1.25e-06	1084	250	24	11544199
Pubmed	Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.	NPIPA1 NPIPA5 NPIPA3	1.46e-06	4	250	3	18055785
Pubmed	TCF transcription factors: molecular switches in carcinogenesis.	TCF7 TCF7L2 LEF1	1.46e-06	4	250	3	10528152
Pubmed	Mapping canonical Wnt signaling in the developing and adult retina.	TCF7 TCF7L2 LEF1	1.46e-06	4	250	3	17065530
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KIAA0319L ATG2A ABCA7 TBC1D9 PCNX2 JAG2 TBC1D16 JAK2 PSME4 CASKIN1 PLA2G6 ARHGAP21 DYNC1H1 TBCD SEMA4F ESYT1 POLG ACTR1A MYOF MROH1 MTOR LRP4 POFUT1 NUP188	1.74e-06	1105	250	24	35748872
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DHX9 DOCK5 PHKB PARP4 PXDN IPO5 ZNFX1 MYOF MTOR DOCK7	2.29e-06	202	250	10	33005030
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK4 DOCK5 DOCK10 DOCK7	2.47e-06	14	250	4	12432077
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEKP POTEE POTEF POTEI	3.34e-06	15	250	4	16824795
Pubmed	Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins.	DOCK4 DOCK5 DOCK7	3.63e-06	5	250	3	22158624
Pubmed	Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.	TCF7 TCF7L2 LEF1	3.63e-06	5	250	3	21285352
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DENND4A EMC1 KIAA0319L ATG2A ITGAV COG6 FNIP1 FNIP2 ESYT1 ANGEL1 EPHA2 TYW1 TOR1AIP1 SLC29A1 ZC3HAV1	4.40e-06	504	250	15	34432599
Pubmed	Defining the membrane proteome of NK cells.	PNKP ILF2 CDS2 F5 DHX9 PARP4 LMF2 AP1G1 GNB2 CNOT2 DYNC1H1 IPO5 ESYT1 DOCK10 SLU7 RNF213 ANO10 CPT1A MTOR LSS CHID1 POFUT1 NUP188 SLC29A1	4.48e-06	1168	250	24	19946888
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EMC1 JAG2 LMF2 PXDN AP1G1 UGT8 GNB1 DYNC1H1 TBCD FKRP ESYT1 AHCTF1 RANBP6 CPT1A MTOR EPHA2 MTR LSS POFUT1 NUP188 TOR1AIP1	5.35e-06	942	250	21	31073040
Pubmed	Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP.	TCF7 TCF7L2 LEF1	7.22e-06	6	250	3	24748645
Pubmed	Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain.	TCF7 TCF7L2 LEF1	7.22e-06	6	250	3	23152144
Pubmed	Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors.	GNB1 GNB2 CACNA1B	7.22e-06	6	250	3	9238069
Pubmed	Mammalian Golgi-associated Bicaudal-D2 functions in the dynein-dynactin pathway by interacting with these complexes.	DYNC1H1 DYNC1I1 ACTR1A	7.22e-06	6	250	3	11483508
Pubmed	Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse.	TCF7 TCF7L2 LEF1	7.22e-06	6	250	3	9488439
Pubmed	SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts.	TCF7 TCF7L2 LEF1	7.22e-06	6	250	3	20128911
Pubmed	Dazap2 modulates transcription driven by the Wnt effector TCF-4.	TCF7 TCF7L2 LEF1	7.22e-06	6	250	3	19304756
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	EMC1 ATG2A ITGAV JAG2 LMF2 UGT8 GNB1 SLC27A2 ESYT1 ANO10 SMPD2 TYW1 TOR1AIP1 ZC3HAV1	8.69e-06	468	250	14	31056421
Pubmed	β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells.	TCF7 TCF7L2 LEF1	1.26e-05	7	250	3	32820720
Pubmed	RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.	TCF7 TCF7L2 LEF1	1.26e-05	7	250	3	18772112
Pubmed	Gene expression analysis of canonical Wnt pathway transcriptional regulators during early morphogenesis of the facial region in the mouse embryo.	TCF7 TCF7L2 LEF1	1.26e-05	7	250	3	19303461
Pubmed	Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis.	HOXA4 CYP26C1 CYP26B1 EPHA2	1.42e-05	21	250	4	30254164
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	HAUS6 ACACB KIAA0319L DHX9 DOCK5 PEX5 DGCR8 ARHGAP21 DYNC1H1 SFSWAP ESYT1 ANGEL1 RNF213 EPHA2 DOCK7 RBM5 TOR1AIP1 ZC3HAV1	1.54e-05	777	250	18	35844135
Pubmed	Gβγ interacts with mTOR and promotes its activation.	GNB1 GNB2 MTOR	2.00e-05	8	250	3	24462769
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	TNFRSF10B ITGAV KCNN4 GNB2 ESYT1 DOCK10 GJC1 MYOF EPHA2 DOCK7 TOR1AIP1 ZC3HAV1	2.09e-05	377	250	12	38117590
Pubmed	Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis.	TCF7 TCF7L2 LEF1	2.99e-05	9	250	3	17335794
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTEKP POTEE POTEI	2.99e-05	9	250	3	16364570
Pubmed	Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.	F5 F8	5.15e-05	2	250	2	26599105
Pubmed	The molecular basis of factor V and VIII procofactor activation.	F5 F8	5.15e-05	2	250	2	19765210
Pubmed	Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis.	TCF7 LEF1	5.15e-05	2	250	2	8223271
Pubmed	Molecular interaction of NMDA receptor subunit NR3A with protein phosphatase 2A.	GRIN3A PTPA	5.15e-05	2	250	2	15194871
Pubmed	Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.	F5 F8	5.15e-05	2	250	2	28057741
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEE POTEF	5.15e-05	2	250	2	19669888
Pubmed	Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.	TCF7L2 LEF1	5.15e-05	2	250	2	21599871
Pubmed	The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.	F5 F8	5.15e-05	2	250	2	15735794
Pubmed	Prolonged Starvation Causes Up-Regulation of AQP1 in Adipose Tissue Capillaries of AQP7 Knock-Out Mice.	AQP7P3 AQP7	5.15e-05	2	250	2	27455244
Pubmed	Reaching and grasping phenotypes in the mouse (Mus musculus): a characterization of inbred strains and mutant lines.	DYNC1H1 KY	5.15e-05	2	250	2	17574766
Pubmed	Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.	F5 F8	5.15e-05	2	250	2	17287628
Pubmed	Aquaporin 7 is a beta-cell protein and regulator of intraislet glycerol content and glycerol kinase activity, beta-cell mass, and insulin production and secretion.	AQP7P3 AQP7	5.15e-05	2	250	2	17576812
Pubmed	Activated protein C has a regulatory role in factor VIII function.	F5 F8	5.15e-05	2	250	2	33512448
Pubmed	Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.	F8 DLC1	5.15e-05	2	250	2	24553346
Pubmed	Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis.	SMPD1 SMPD2	5.15e-05	2	250	2	15175033
Pubmed	Aquaporin 7 expression in postimplantation mouse uteri: a potential role for glycerol transport in uterine decidualization.	AQP7P3 AQP7	5.15e-05	2	250	2	21130427
Pubmed	The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator.	AQP7P3 AQP7	5.15e-05	2	250	2	19297367
Pubmed	Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets.	ACACB CPT1A	5.15e-05	2	250	2	12920182
Pubmed	Dynamic subcellular localization of aquaporin-7 in white adipocytes.	AQP7P3 AQP7	5.15e-05	2	250	2	25643985
Pubmed	The Dynamic Localization of Cytoplasmic Dynein in Neurons Is Driven by Kinesin-1.	DYNC1H1 DYNC1I1	5.15e-05	2	250	2	27210554
Pubmed	EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.	MTOR EPHA2	5.15e-05	2	250	2	20360610
Pubmed	Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.	TCF7 LEF1	5.15e-05	2	250	2	16424171
Pubmed	Positive selection of a gene family during the emergence of humans and African apes.	NPIPA1 NPIPA8	5.15e-05	2	250	2	11586358
Pubmed	Aquaporin-7 Regulates the Response to Cellular Stress in Breast Cancer.	AQP7P3 AQP7	5.15e-05	2	250	2	32631905
Pubmed	IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.	IDO1 MTOR	5.15e-05	2	250	2	27174915
Pubmed	Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf.	EGF LEF1	5.15e-05	2	250	2	1783375
Pubmed	Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.	F5 F8	5.15e-05	2	250	2	22613792
Pubmed	TCF7 and LEF-1 downregulation in sepsis promotes immune suppression by inhibiting CD4+ T cell proliferation.	TCF7 LEF1	5.15e-05	2	250	2	37741305
Pubmed	Localization of am3 using EL congenic mouse strains.	EGF LEF1	5.15e-05	2	250	2	15790735
Pubmed	Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation.	AQP7P3 AQP7	5.15e-05	2	250	2	15746100
Pubmed	Substrate specificity of RdgB protein, a deoxyribonucleoside triphosphate pyrophosphohydrolase.	PITPNC1 PITPNM1	5.15e-05	2	250	2	17090528
Pubmed	Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines.	JAK2 MTOR	5.15e-05	2	250	2	25931349
Pubmed	Replication study of RAD54B and GREB1 polymorphisms and risk of PCOS in Han Chinese.	RAD54B GREB1	5.15e-05	2	250	2	23876972
Pubmed	AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism.	AQP7P3 AQP7	5.15e-05	2	250	2	17077387
Pubmed	A new role for aquaporin 7 in insulin secretion.	AQP7P3 AQP7	5.15e-05	2	250	2	22415076
Pubmed	Different roles of G protein subunits beta1 and beta2 in neutrophil function revealed by gene expression silencing in primary mouse neutrophils.	GNB1 GNB2	5.15e-05	2	250	2	20525682
Pubmed	Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.	TCF7 LEF1	5.15e-05	2	250	2	27044748
Pubmed	The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).	HIC1 EPHA2	5.15e-05	2	250	2	22184117
Pubmed	Over-expression of AQP7 contributes to improve insulin resistance in adipocytes.	AQP7P3 AQP7	5.15e-05	2	250	2	22877989
Pubmed	JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation.	F5 JAK2	5.15e-05	2	250	2	17849060
Pubmed	Aquaporin 7 is upregulated through the PI3K-Akt pathway and modulates decidualisation of endometrial stromal cells.	AQP7P3 AQP7	5.15e-05	2	250	2	37879294
Pubmed	Involvement of aquaporin-7 in the cutaneous primary immune response through modulation of antigen uptake and migration in dendritic cells.	AQP7P3 AQP7	5.15e-05	2	250	2	21968069
Pubmed	Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system.	WWC1 TCF7L2	5.15e-05	2	250	2	24072042
Pubmed	Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.	TCF7 LEF1	5.15e-05	2	250	2	9462507
Pubmed	Aquaporin-7 Facilitates Proliferation and Adipogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells by Regulating Hydrogen Peroxide Transport.	AQP7P3 AQP7	5.15e-05	2	250	2	37432580
Pubmed	β1,6 GlcNAc branches-modified protein tyrosine phosphatase alpha enhances its stability and promotes focal adhesion formation in MCF-7 cells.	MGAT5 PTPA	5.15e-05	2	250	2	27965091
Pubmed	Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function.	TCF7 LEF1	5.15e-05	2	250	2	38169425
Pubmed	Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.	F5 F8	5.15e-05	2	250	2	11091190
Pubmed	Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping.	AQP7P3 AQP7	5.15e-05	2	250	2	9714739
Pubmed	Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.	TCF7 LEF1	5.15e-05	2	250	2	22111711
Pubmed	IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.	IDO1 F8	5.15e-05	2	250	2	26426076
Pubmed	Cryoprotectants up-regulate expression of mouse oocyte AQP7, which facilitates water diffusion during cryopreservation.	AQP7P3 AQP7	5.15e-05	2	250	2	23290745
Pubmed	Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells.	TCF7 LEF1	5.15e-05	2	250	2	26490636
Pubmed	Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.	IDO1 CPT1A	5.15e-05	2	250	2	27667153
Pubmed	CPT1A modulates PI3K/Akt/mTOR pathway to promote preeclampsia.	CPT1A MTOR	5.15e-05	2	250	2	36702079
Pubmed	Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel.	AQP7P3 AQP7	5.15e-05	2	250	2	11457862
Pubmed	Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.	TCF7 LEF1	5.15e-05	2	250	2	30918012
Pubmed	Cardioprotective effect of St. Thomas' Hospital No. 2 solution against age-related changes in aquaporin-7-deficient mice.	AQP7P3 AQP7	5.15e-05	2	250	2	37691043
Pubmed	Aquaporin7 expression during perinatal development of mouse brain.	AQP7P3 AQP7	5.15e-05	2	250	2	17052846
Pubmed	Signalling sphingomyelinases: which, where, how and why?	SMPD1 SMPD2	5.15e-05	2	250	2	10216276
Pubmed	Morphologic and functional analysis of sperm and testes in Aquaporin 7 knockout mice.	AQP7P3 AQP7	5.15e-05	2	250	2	17123523
Pubmed	Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9.	AQP7P3 AQP7	5.15e-05	2	250	2	11972053
Pubmed	Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue.	AQP7P3 AQP7	5.15e-05	2	250	2	15591341
Pubmed	Structure and inhibition of human diamine oxidase.	AOC1 AOC3	5.15e-05	2	250	2	19764817
Pubmed	GnT-V promotes chemosensitivity to gemcitabine in bladder cancer cells through β1,6 GlcNAc branch modification of human equilibrative nucleoside transporter 1.	MGAT5 SLC29A1	5.15e-05	2	250	2	30143259
Pubmed	Aquaporin7 plays a crucial role in tolerance to hyperosmotic stress and in the survival of oocytes during cryopreservation.	AQP7P3 AQP7	5.15e-05	2	250	2	26634435
Pubmed	Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene.	IDO1 LEF1	5.15e-05	2	250	2	21980470
Pubmed	Tcf1 and Lef1 provide constant supervision to mature CD8+ T cell identity and function by organizing genomic architecture.	TCF7 LEF1	5.15e-05	2	250	2	34615872
Cytoband	Ensembl 112 genes in cytogenetic band chr2q21	POTEKP POTEE MGAT5 POTEF LCT POTEI	1.85e-04	151	249	6	chr2q21
Cytoband	16p13.11	NPIPA1 NPIPA5 NPIPA3	2.58e-04	23	249	3	16p13.11
Cytoband	2q21.1	POTEKP POTEE POTEF POTEI	2.85e-04	58	249	4	2q21.1
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEKP POTEE POTEF POTEI	4.38e-06	13	164	4	685
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4A DENND2B FNIP1 FNIP2	7.11e-05	25	164	4	504
GeneFamily	Cytochrome P450 family 26	CYP26C1 CYP26B1	2.44e-04	3	164	2	1013
GeneFamily	Dyneins, axonemal	DNAH3 DNAH10 DNAI2	4.54e-04	17	164	3	536
GeneFamily	Phosphatidylinositol transfer proteins	PITPNC1 PITPNM1	1.20e-03	6	164	2	1151
Coexpression	GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN	ACACB JAK2 NELL1 MMP19 SLC27A2 SEMA4F DNAH3 ESYT1 RANBP6 PRELID3A EGF	2.86e-06	199	244	11	M8385
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	ATG2A ITGA7 DHX9 PARP4 MGAT5 TBCD SLC27A2 TCF7 ESYT1 POLG LRP4 SLC29A1	1.19e-05	276	244	12	M3063
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	HOXA4 PROKR1 PACS2 FKRP RHOBTB3 ENC1 DOCK10 LCT MYOF LSS	1.95e-05	200	244	10	M6273
Coexpression	PARENT_MTOR_SIGNALING_UP	DYRK4 ITGA7 DENND2B DHX9 JAK2 DGLUCY KLHL9 SUPT6H PEX5 GYG2 SEMA4F POLG ANO10 MTOR RBM5 SMPD1 NUP188	2.60e-05	567	244	17	M16909
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5	ACACB DGLUCY OLFML1 KLHL23 ACSS3 SEMA4F CYP26B1 CAPN6 DOCK10 RNF213 MYOF BCL11B TNN	3.23e-06	244	233	13	Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1	ACACB NELL1 DGLUCY OLFML1 ACSS3 SEMA4F CYP26B1 CAPN6 DOCK10 RNF213 ABCC9 MYOF BCL11B TNN KCTD14	1.62e-05	371	233	15	Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3	ACACB NELL1 DGLUCY OLFML1 ACSS3 SEMA4F CYP26B1 CAPN6 DOCK10 RNF213 ABCC9 MYOF BCL11B TNN KCTD14	2.42e-05	384	233	15	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1	DENND4A ACACB CD300A JAK2 NELL1 DGLUCY OLFML1 KLHL23 GRIN3A TMEM236 ACSS3 SEMA4F CYP26B1 ICA1 CAPN6 DOCK10 RNF213 ABCC9 HIF3A PITPNM1 MYOF BCL11B TNN KCTD14	3.89e-05	878	233	24	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL7 TBC1D16 MGAT5 TCF7L2 ENC1 CA13 ZNFX1 AQP7 ELMO3 KCTD14	5.00e-08	173	248	10	0a0cd40bb5f61431fe34758626c8a63ec610a8a5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 RHOBTB3 CPT1A EGF	8.77e-07	182	248	9	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 ACACB MGAT5 RHOBTB3 HIF3A LIFR EGF MTR LRP4	1.25e-06	190	248	9	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ELAPOR2 SYT9 TMTC2 DOCK5 UGT8 PACS2 ARHGAP21 CNDP1 CLDND1	1.49e-06	194	248	9	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRV1 KCNN4 SPDEF WWC1 ICA1 ANO10 FIGN EGF SLC44A3	1.92e-06	200	248	9	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB ADGRV1 PITPNC1 ITGA7 WWC1 ACSS3 HIF3A STON2 DOCK7	1.92e-06	200	248	9	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ELAPOR2 ADGRV1 F5 ANKAR UGT8 CACNA1B TDRD5 DNAH10	3.62e-06	162	248	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-Erythroid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B3GALT4 PITPNC1 TCF7 FKRP DOCK10 BCL11B LEF1	4.45e-06	118	248	7	04355cac58ec046730365d6649aa1e31396901c3
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KATNAL2 CATSPERD GRIN3A CFAP161 MROH8 TNN DNAI2 STYXL1	6.67e-06	176	248	8	d6d7e4e937d49a5c0d16322c8dd3bf9e97eb8732
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KATNAL2 CATSPERD GRIN3A CFAP161 MROH8 TNN DNAI2 STYXL1	6.67e-06	176	248	8	c03d80df2550c0d2b0452326480d6bf21d20fdd2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB ADGRV1 NELL1 MGAT5 UGT8 RHOBTB3 ADGB EGF	7.25e-06	178	248	8	4df6218b20c2f076c22346d23260964cc0d73e65
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NPIPB4 DOCK5 MGAT5 FNIP2 CYP26B1 CA13 CPT1A KCTD14	7.25e-06	178	248	8	50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A F8 PEX5 SEMA4F AHCTF1 TMEM39B TSEN2 LIFR	8.19e-06	181	248	8	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A F8 PEX5 SEMA4F AHCTF1 TMEM39B TSEN2 LIFR	8.19e-06	181	248	8	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HAUS6 PITPNC1 TCF7 BCL11B LSS LEF1	8.59e-06	86	248	6	79c4326df78f0a5b3ef13b2fb4e5074934536e35
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 RHOBTB3 EGF	8.87e-06	183	248	8	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FHIP1A WWC1 SLC27A2 LARGE2 STON2 SHISAL2B SLC44A3	8.87e-06	183	248	8	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FHIP1A WWC1 SLC27A2 LARGE2 ICA1 STON2 SHISAL2B	9.23e-06	184	248	8	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 RHOBTB3 EGF	9.61e-06	185	248	8	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9 FIGN	1.04e-05	187	248	8	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 RHOBTB3 EGF	1.04e-05	187	248	8	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB ADGRV1 DOCK5 ACSS3 TCF7L2 HIF3A STON2 LRP4	1.04e-05	187	248	8	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9 FIGN	1.04e-05	187	248	8	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB DOCK5 UGT8 CNDP1 BEST1 HIF3A STON2 LRP4	1.08e-05	188	248	8	505b6b4277d7dea87aee27191d0acca67928b8e6
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	DENND4A NPIPB4 AP1G1 DYNC1H1 AHCTF1 DOCK10 RNF213 ZC3HAV1	1.08e-05	188	248	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNC1 PCNX2 MGAT5 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	1.12e-05	189	248	8	df30478b288084a1bd48f660409dcc784040897c
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB DOCK5 UGT8 CNDP1 DOCK10 HIF3A STON2 LRP4	1.12e-05	189	248	8	784ace2be87f2ecb19490f4974f63a559516e0eb
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB DOCK5 UGT8 CNDP1 DOCK10 HIF3A STON2 LRP4	1.12e-05	189	248	8	37ecbd73408d462b47d7e5611f203143e08a2689
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 NELL1 MGAT5 UGT8 FHIP1A RHOBTB3 BCL11B EGF	1.17e-05	190	248	8	cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCell	COVID-19-Heart-CM_4\|Heart / Disease (COVID-19 only), tissue and cell type	F5 FHIP1A DYNC1I1 ACSS3 FNIP2 ICA1 EGF MROH1	1.17e-05	190	248	8	3729648a17093b438398b82e32bbccc3af7b8c5d
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FHIP1A WWC1 LARGE2 ICA1 CAPN6 SHISAL2B SLC44A3	1.21e-05	191	248	8	72dbd2e0fabfca8d6f604df35277d3574739a0b3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB DOCK5 UGT8 CNDP1 BEST1 HIF3A STON2 LRP4	1.21e-05	191	248	8	f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIC1 ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9	1.21e-05	191	248	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIC1 ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9	1.21e-05	191	248	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 FHIP1A EGF	1.21e-05	191	248	8	963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB DOCK5 UGT8 CNDP1 BEST1 HIF3A STON2 LRP4	1.21e-05	191	248	8	a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DENND4A NPIPB4 PITPNC1 AP1G1 DOCK10 RNF213 BCL11B ZC3HAV1	1.26e-05	192	248	8	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK4 DENND4A NPIPB4 NPIPB3 PITPNC1 NPIPB5 MGAT5 FAM168A	1.31e-05	193	248	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A NPIPB4 NPIPB3 PITPNC1 NPIPB5 BCL11B LEF1 ZC3HAV1	1.31e-05	193	248	8	9c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCell	PCW_05-06-Epithelial\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FHIP1A WWC1 SLC27A2 LARGE2 ICA1 SHISAL2B SLC44A3	1.36e-05	194	248	8	47a1369c22fcbfe00b08376eb610a61c355548db
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FHIP1A WWC1 SLC27A2 LARGE2 ICA1 SHISAL2B SLC44A3	1.36e-05	194	248	8	acd5ba9a097595d4caab4f05440531c65a4aa7bc
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	KATNAL2 ANKMY1 CFAP161 DNAH3 DNAH10 MRPL45 ADGB LSS	1.57e-05	198	248	8	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	Bronchus_Control_(B.)-Endothelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ELAPOR2 JAG2 FZD9 NELL1 MMP10 GRP BCL11B LRP4	1.57e-05	198	248	8	feac39036b5c0ab97b524cc366286942d136d42f
ToppCell	Sigmoid-(1)_T_cell-(14)_Tcm\|Sigmoid / shred on region, Cell_type, and subtype	HIC1 F5 KLHL9 PLA2G6 TCF7 BCL11B MTOR LEF1	1.63e-05	199	248	8	ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c
ToppCell	Sigmoid-T_cell-Tcm\|Sigmoid / Region, Cell class and subclass	HIC1 F5 KLHL9 PLA2G6 TCF7 BCL11B MTOR LEF1	1.63e-05	199	248	8	f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCNX2 GDAP1L1 CYP26C1 GRIN3A FHIP1A TMEM236 SLC36A3	1.64e-05	144	248	7	e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCell	Macroglial\|World / cells hierarchy compared to all cells using T-Statistic	ACACB DOCK5 UGT8 CNDP1 BEST1 HIF3A STON2 LRP4	1.69e-05	200	248	8	e6935ad49216d2500c15c05cbc2b89402c65e838
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMTC2 ADGRV1 KCNN4 FHIP1A WWC1 ICA1 EGF SLC44A3	1.69e-05	200	248	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Glia_progenitor_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	UGT8 MMP19 ACSS3 TCF7L2 DOCK10 EPHA2 TGDS LRP4	1.69e-05	200	248	8	0b91c8da21ba488109f15c9b927c1dcaf8c6b0ae
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PITPNC1 SLC27A2 TCF7 ESYT1 CLDND1 BCL11B LEF1	2.33e-05	152	248	7	06fa7d8acc8f56de00af9bee17884595b300410e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PITPNC1 SLC27A2 TCF7 ESYT1 CLDND1 BCL11B LEF1	2.33e-05	152	248	7	405d19b290232bb3e564d61c0cff0cfdd247bdff
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PITPNC1 SLC27A2 TCF7 ESYT1 CLDND1 BCL11B LEF1	2.43e-05	153	248	7	b101cb1bce5db785dab46b6c4f7be9c3efe48b0e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PITPNC1 SLC27A2 TCF7 ESYT1 CLDND1 BCL11B LEF1	2.43e-05	153	248	7	487388082bb596809ba1caf9197626b6814792ab
ToppCell	COVID-19_Severe-Lymphoid_T/NK-dn_T\|COVID-19_Severe / Disease group, lineage and cell class	PITPNC1 SLC27A2 TCF7 ESYT1 CLDND1 BCL11B LEF1	2.75e-05	156	248	7	83f25683e0f55472b56f915ee176fc05efc33a31
ToppCell	LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMP19 BEST1 ADGB MROH8 ZSCAN21 STON2	3.88e-05	112	248	6	9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALT4 KLHL23 TCF7 DOCK10 POMC BCL11B LEF1	3.94e-05	165	248	7	475905d608fac628960188ae4a18010b8097417e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	AOC1 F5 ZNF550 TCF7 DOCK10 BCL11B LEF1	4.25e-05	167	248	7	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	Control-Epithelial_alveolar-Mes-Like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B3GALT4 PEX5 CFAP161 CYP26B1 DNAH10 MTR	4.72e-05	116	248	6	df7609503782d8d7e4f31ed2a626916e5474d5bc
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	4.94e-05	171	248	7	539ea88acc6f948efdeae8b69e5c5ffaee29f1d9
ToppCell	Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	AOC1 CFAP161 DNAH3 DNAH10 TTLL8 STYXL1	4.95e-05	117	248	6	91936a3ffbfa29024ced9d01df962b4ccfaf8966
ToppCell	Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	AOC1 CFAP161 DNAH3 DNAH10 TTLL8 STYXL1	4.95e-05	117	248	6	e33ec9044541d2ef53f6633891238559b01b7957
ToppCell	Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--\|Hippocampus / BrainAtlas - Mouse McCarroll V32	AOC1 CFAP161 DNAH3 DNAH10 TTLL8 STYXL1	4.95e-05	117	248	6	454efceabe739cdf293f81c8a938811f12321a47
ToppCell	Hippocampus-Macroglia-CSF_related-EPENDYMAL\|Hippocampus / BrainAtlas - Mouse McCarroll V32	AOC1 CFAP161 DNAH3 DNAH10 TTLL8 STYXL1	4.95e-05	117	248	6	409b3ab16786bced8c9bc9c0e89b0078402f365a
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D9 DHX9 UGT8 DOCK10 PITPNM1 ADGB MYOF	5.13e-05	172	248	7	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	5.13e-05	172	248	7	0fc692be845d4225ff8b63bf9195724fc8510c2c
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF10B KCNN4 SEMA4F TEX11 KY BCL11B LEF1	5.13e-05	172	248	7	33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ACACB ADGRV1 NELL1 MGAT5 UGT8 EGF	5.13e-05	172	248	7	1565f38266891c3acf49778838de134c5dee5460
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELAPOR2 DENND4A F8 JAG2 NELL1 KY MTOR	5.52e-05	174	248	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	5.93e-05	176	248	7	9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	5.93e-05	176	248	7	bb41e9478373726eb460af764de0277b2d09928e
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	5.93e-05	176	248	7	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABL2 KIAA0319L GDAP1L1 DLC1 GYG2 POTEF CA13	5.93e-05	176	248	7	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	5.93e-05	176	248	7	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	6.14e-05	177	248	7	f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9	6.14e-05	177	248	7	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA7 DENND2B DLC1 KCNAB1 DYNC1I1 GJC1 ABCC9	6.14e-05	177	248	7	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLB1 PITPNC1 TCF7 NPIPB11 BCL11B TGDS LEF1	6.14e-05	177	248	7	3d1b142aa2bd18df14816abaca356596b297394e
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	AOC1 NPIPB4 IDO1 NPIPB5 NDUFAF5 BCL11B LEF1	6.59e-05	179	248	7	5f7e6670a0e906a0a5bc75735408361d88e78fa2
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA7 RAD54B KCNAB1 NDUFAF5 GJC1 KY AOC3	6.59e-05	179	248	7	d76a05f1fee7f2f7b7b7994d3622e96f02b49432
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA7 RAD54B KCNAB1 NDUFAF5 GJC1 KY AOC3	6.59e-05	179	248	7	6be47c877250968a916c711ba0787eb7b4c5443d
ToppCell	LPS-antiTNF-Lymphocytic_NKT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	6.59e-05	179	248	7	ecea75c568911ff56939c9f67ab901497bd4356c
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NPIPB4 ZNF550 KCNN4 SMIM29 ICA1 KIAA0825 MTOR	6.83e-05	180	248	7	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	LPS_only-Lymphocytic_NKT-T_cells-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	6.83e-05	180	248	7	dcef253f2e97e4436b1b04e8a06a53ff6e64522c
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT5 KCNN4 SEMA4F TCF7 RANBP6 BCL11B ZC3HAV1	7.07e-05	181	248	7	8a8061725e718c89a4c751a415120c5312acc757
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPF1 PLB1 FZD9 RAD54B CA13 LEF1 SLC29A1	7.07e-05	181	248	7	145fae2746c5212640b7b11b04a7759ba8e5c322
ToppCell	LPS_only-Lymphocytic_NKT-T_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNC1 PCNX2 TCF7 DOCK10 BCL11B LEF1 ZC3HAV1	7.07e-05	181	248	7	a4347ae554e6dcf03c7001a2b69332b377c7c034
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPF1 PLB1 FZD9 RAD54B CA13 LEF1 SLC29A1	7.07e-05	181	248	7	a9f1fc5973cffdbeb7d1f5c41534422d85d596ff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBPAP CFAP161 ACSS3 CAPN6 TTLL8 ADGB STYXL1	7.32e-05	182	248	7	587636c0f127231de21acd8aa632b74ff22ca8c2
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBPAP KLHL23 TMEM236 GJC1 ABCC9 DNAI2 KCTD14	7.32e-05	182	248	7	c84f44391932080df31c8765e363c3dff64b2bd1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBPAP CFAP161 ACSS3 CAPN6 TTLL8 ADGB STYXL1	7.32e-05	182	248	7	adfadd7893e74b3002f13f00875e3667d3493e0c
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F8 QRFPR DLC1 PXDN CYP26B1 GJC1 LIFR	7.32e-05	182	248	7	f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ELAPOR2 ADGRV1 DLC1 WWC1 ACSS3 ABCC9 LIFR	7.57e-05	183	248	7	6847c1252d6bb105524f812658112517fd351eab
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	DLC1 KLHL23 KCNAB1 GRIN3A GJC1 ABCC9 FIGN	7.57e-05	183	248	7	273db6a3b00a93ca852498471187b642b5368185
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MMP19 RHOBTB3 FIGN KIAA0825 AOC3 GREB1 NUP188	7.57e-05	183	248	7	5377b4fbd8fdfe68933b4c0965aa9525f7f31591
ToppCell	Mesenchymal_cells-Osteoblasts\|Mesenchymal_cells / Lineage and Cell class	PLB1 COG6 TCF7 ICA1 FIGN EPHA2 KCTD14	7.57e-05	183	248	7	d6b52d52fe9a7a6c798947f05420d79fe12e4662
Drug	Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ATG2A FBXL5 KLHL9 FAM168A LRP5L IPO5 TCF7L2 ENC1 MTOR EPHA2 SCPEP1 POFUT1	9.88e-07	196	235	12	7224_DN
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; HL60; HT_HG-U133A	EMC1 CDS2 KIAA0319L ABCA7 DOCK5 DGLUCY FAM168A DNAH3 ICA1 PTPA SMPD1 POFUT1	1.04e-06	197	235	12	3096_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	TNFRSF10B DLC1 RAD54B KCNAB1 GYG2 PLA2G6 LRP5L TBCD CPT1A RNF17 EGF POFUT1	1.04e-06	197	235	12	1491_UP
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	CUL7 MAP3K12 ABCA7 PCNX2 JAK2 KCNAB1 TBCD IPO5 ICA1 CPT1A AOC3 SMPD2	1.22e-06	200	235	12	2127_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	EMC1 TNFRSF10B CUL7 MAP3K12 DOCK10 CPT1A BCL11B PRELID3A RBM5 SMPD1 TOR1AIP1	6.18e-06	195	235	11	3721_DN
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; MCF7; HT_HG-U133A	CUL7 F5 DENND2B CHRNB3 FBXO38 LMF2 DLC1 UGT8 NDUFAF5 ADGB LSS	6.49e-06	196	235	11	4807_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; HL60; HG-U133A	NDUFB6 JAG2 PEX5 IPO5 DNAH3 TCF7L2 SFSWAP ANGEL1 PTPA FAM222B SLC29A1	6.49e-06	196	235	11	1775_DN
Drug	Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A	ABCA7 JAK2 IPO5 POLG ICA1 PITPNM1 MYOF PTPA EGF LEF1 SLC29A1	6.49e-06	196	235	11	2058_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	DPF1 KIAA0319L ITGA7 KCNAB1 TBCD ACSS3 RHOBTB3 RNF17 PRELID3A NUP188 FBXO21	6.81e-06	197	235	11	5057_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	CUL7 TBC1D9 KLHL9 LMF2 TCF7 TCF7L2 ICA1 BCL11B LSS POFUT1 SLC29A1	7.15e-06	198	235	11	2246_DN
Drug	cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A	EMC1 ABL2 DENND2B TBC1D9 LMF2 ZNF550 WWC1 DNAH3 ENC1 HIF3A MTOR	7.86e-06	200	235	11	379_DN
Drug	polybrene	F5 F8 PHKB PXDN EGF GLCE	2.65e-05	57	235	6	CID000024769
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; HL60; HT_HG-U133A	CD300A F5 ABCA7 LMF2 FAM168A TCF7 ANGEL1 MYOF LSS SLC29A1	2.72e-05	188	235	10	2490_DN
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	LMF2 PSME4 RAD54B IPO5 TCF7 CLDND1 CPT1A LSS POFUT1 GREB1	2.98e-05	190	235	10	3331_DN
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	DENND4A EMC1 CDS2 KIAA0319L KCNN4 SPDEF WWC1 SEMA4F BCL11B LSS	3.12e-05	191	235	10	2850_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	DOCK4 EMC1 ACACB CDS2 KIAA0319L MAP3K12 TCF7 DOCK10 GLCE POFUT1	3.56e-05	194	235	10	2430_DN
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	EMC1 CUL7 DLC1 SPDEF TCF7 TCF7L2 NDUFAF5 PITPNM1 DNAI2 POFUT1	3.56e-05	194	235	10	5354_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	SUPT6H PACS2 DNAH3 TCF7L2 RHOBTB3 ICA1 PTPA LSS FBXO21 ZC3HAV1	3.72e-05	195	235	10	1144_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ANKMY1 DHX9 JAK2 KLHL9 DLC1 IPO5 TCF7L2 POLG ELMO3 SCPEP1	3.88e-05	196	235	10	4776_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	EMC1 KIAA0319L CUL7 JAG2 SUPT6H RAD54B ICA1 RNF17 MYOF POFUT1	3.88e-05	196	235	10	3256_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	PCNX2 FZD9 DLC1 DGCR8 SEMA4F FKRP LIFR MYOF DNAI2 POFUT1	3.88e-05	196	235	10	3400_UP
Drug	Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A	ACACB ANKMY1 F5 DLC1 GYG2 PLA2G6 CYP26B1 ICA1 CPT1A TNN	3.88e-05	196	235	10	2862_UP
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	JAG2 JAK2 FBXO38 RAD54B PEX5 ELMO3 BCL11B MTOR EPHA2 SMPD2	4.05e-05	197	235	10	7478_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	EMC1 FBXL5 PEX5 DNAH3 TCF7 TCF7L2 PIGV EPHA2 RBM5 POFUT1	4.05e-05	197	235	10	6960_DN
Drug	SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A	KIAA0319L TNFRSF10B DENND2B PCNX2 LMF2 MMP19 TCF7 POLG SMPD1 POFUT1	4.05e-05	197	235	10	7061_UP
Drug	16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	TNFRSF10B PITPNC1 RAD54B PLA2G6 DGCR8 TBCD DOCK10 PITPNM1 ELMO3 SMPD2	4.23e-05	198	235	10	7509_UP
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	ITGA7 DOCK5 LMF2 PEX5 KCNAB1 ACSS3 RHOBTB3 LIFR CD1C KCTD14	4.23e-05	198	235	10	5862_UP
Drug	sulindac; Up 200; 100uM; MCF7; HG-U133A	DYRK4 LMF2 MMP19 SEMA4F ANGEL1 ANO10 CPT1A LCT SCPEP1 TOR1AIP1	4.23e-05	198	235	10	168_UP
Drug	Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A	TNFRSF10B F8 FBXL5 SUPT6H IPO5 TCF7L2 ENC1 CLDND1 GLCE LSS	4.41e-05	199	235	10	6268_DN
Drug	AC1Q6X1Y	MTOR SMPD1 SMPD2	8.71e-05	9	235	3	CID000062500
Drug	maltulose	AOC1 DYNC1H1 LCT CCK AOC3	9.80e-05	45	235	5	CID000087177
Drug	Amoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT_HG-U133A	DHX9 JAK2 KLHL9 PSME4 SPDEF RHOBTB3 GREB1 SLC29A1 ZC3HAV1	1.36e-04	185	235	9	2620_DN
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	TNFRSF10B DHX9 JAK2 PEX5 DGCR8 LSS POFUT1 GREB1 TOR1AIP1	1.47e-04	187	235	9	6872_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; MCF7; HT_HG-U133A	EMC1 TNFRSF10B DOCK5 JAK2 SPDEF TBCD CPT1A GREB1 SLC29A1	1.53e-04	188	235	9	3480_DN
Drug	4-Ser-8-ile-oxytocin	KCNN4 POMC CCK MTR	1.61e-04	27	235	4	CID000123960
Drug	2-Amino-4-	AOC1 AOC3 MTR	1.68e-04	11	235	3	CID006326973
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A	DPF1 ACACB KIAA0319L ANKMY1 ITGA7 MGAT5 PLA2G6 NDUFAF5 POFUT1	1.73e-04	191	235	9	3905_UP
Drug	azidopine	AOC1 TBC1D9 PTPA AOC3	1.86e-04	28	235	4	CID000656406
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	KIAA0319L LMF2 PACS2 PLA2G6 DGCR8 BEST1 TCF7 RHOBTB3 PITPNM1	1.87e-04	193	235	9	3100_DN
Drug	Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; HL60; HT_HG-U133A	JAG2 DOCK5 SUPT6H PLA2G6 TBCD TCF7 ANGEL1 LSS SMPD1	1.87e-04	193	235	9	2142_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	ACACB TNFRSF10B MAP3K12 SUPT6H PEX5 DGCR8 LRP5L PTPA EGF	1.94e-04	194	235	9	1211_DN
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A	DENND4A KIAA0319L PEX5 TCF7L2 ICA1 GJC1 BCL11B GLCE KCTD14	1.94e-04	194	235	9	2069_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	EMC1 CDS2 JAG2 DOCK5 TBCD LSS SMPD1 POFUT1 SLC29A1	1.94e-04	194	235	9	2485_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	ANKMY1 PACS2 WWC1 SLC27A2 TCF7L2 SFSWAP PIGV SMPD2 SLC29A1	1.94e-04	194	235	9	6178_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A	FBXL5 KLHL9 LMF2 TCF7L2 MTR SMPD1 SMPD2 POFUT1 GREB1	1.94e-04	194	235	9	7221_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ANKMY1 ATG2A CUL7 MAP3K12 RAD54B KCNAB1 BCL11B EPHA2 POFUT1	1.94e-04	194	235	9	7354_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ACACB KIAA0319L DENND2B FAM168A GYG2 IPO5 LSS POFUT1 FBXO21	1.94e-04	194	235	9	6066_DN
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A	DPF1 ACACB ABCA7 DLC1 PLA2G6 DYNC1I1 RNF17 AOC3 POFUT1	2.02e-04	195	235	9	3890_UP
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A	DOCK4 ACACB CDS2 TNFRSF10B JAK2 TCF7L2 ENC1 ANGEL1 CPT1A	2.02e-04	195	235	9	2478_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A	KIAA0319L PCNX2 PLA2G6 DGCR8 TBCD TCF7L2 ENC1 DOCK10 POFUT1	2.02e-04	195	235	9	2740_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	KIAA0319L DOCK5 JAK2 DLC1 KCNAB1 DGCR8 PITPNM1 MYOF NUP188	2.02e-04	195	235	9	4170_DN
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	JAK2 PEX5 TBCD ICA1 DOCK10 CPT1A SMPD2 POFUT1 SLC29A1	2.02e-04	195	235	9	2126_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	EMC1 F5 DOCK5 DLC1 PSME4 DGCR8 TCF7L2 RHOBTB3 RBM5	2.02e-04	195	235	9	2708_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	EMC1 TNFRSF10B DHX9 DOCK5 JAK2 DNAH3 CPT1A RBM5 LSS	2.10e-04	196	235	9	5425_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	PHKB PLA2G6 LRP5L TCF7 TCF7L2 ENC1 ELMO3 PRELID3A POFUT1	2.10e-04	196	235	9	3284_DN
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HG-U133A	CHRNB3 PLA2G6 DGCR8 TBCD DNAH3 TCF7L2 SFSWAP TCN2 SMPD2	2.10e-04	196	235	9	1886_UP
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	EMC1 ANKMY1 MAP3K12 KLHL9 LRP5L IPO5 ENC1 MYOF POFUT1	2.10e-04	196	235	9	5669_DN
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A	KIAA0319L TNFRSF10B CUL7 JAG2 FBXO38 LMF2 GYG2 PLA2G6 POFUT1	2.10e-04	196	235	9	5257_DN
Drug	Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A	DENND4A ACACB KLHL9 TBCD TCF7L2 GJC1 LIFR MYOF GLCE	2.10e-04	196	235	9	1820_UP
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	ABL2 ANKMY1 DHX9 PCNX2 PLA2G6 DGCR8 LIFR TOR1AIP1 SLC29A1	2.18e-04	197	235	9	5925_UP
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	KIAA0319L MAP3K12 ABCA7 LMF2 DLC1 TCF7L2 ICA1 PRELID3A POFUT1	2.18e-04	197	235	9	6167_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A	CHRNB3 KCNAB1 TBCD RHOBTB3 GRP PRELID3A SMPD1 SMPD2 POFUT1	2.18e-04	197	235	9	3085_UP
Drug	alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A	CD300A KIAA0319L TNFRSF10B DOCK5 JAK2 TCF7L2 CPT1A GLCE POFUT1	2.18e-04	197	235	9	6169_DN
Drug	Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; HL60; HT_HG-U133A	KIAA0319L MAP3K12 LMF2 KCNAB1 SPDEF DGCR8 ICA1 MYOF PRELID3A	2.18e-04	197	235	9	2384_UP
Drug	Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ABCA7 PLA2G6 DGCR8 MMP19 DNAH3 TCF7L2 LSS POFUT1 GREB1	2.18e-04	197	235	9	2899_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A	DPF1 KIAA0319L DGLUCY DLC1 NDUFAF5 CAPN6 DOCK10 FBXO21 TOR1AIP1	2.18e-04	197	235	9	3672_UP
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A	ZNF550 KCNAB1 DGCR8 NDUFAF5 BCL11B PRELID3A LSS SMPD1 FBXO21	2.18e-04	197	235	9	4326_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	ANKMY1 TNFRSF10B JAK2 FBXO38 PSME4 TCF7L2 POLG CPT1A LEF1	2.18e-04	197	235	9	2110_UP
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A	EMC1 AOC1 TNFRSF10B CUL7 LRP5L DNAH3 TCF7L2 GLCE POFUT1	2.18e-04	197	235	9	1677_UP
Drug	Etanidazole [22668-01-5]; Up 200; 18.6uM; MCF7; HT_HG-U133A	JAG2 FBXO38 LMF2 SPDEF MMP19 TCF7L2 EPHA2 FBXO21 SLC29A1	2.18e-04	197	235	9	6211_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; HL60; HT_HG-U133A	CDS2 JAG2 PEX5 KCNAB1 MMP19 TCF7 ICA1 CD1C POFUT1	2.18e-04	197	235	9	6161_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ABL2 ACACB ANKMY1 MAP3K12 PLA2G6 TBCD ICA1 CPT1A LEF1	2.18e-04	197	235	9	2103_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	DOCK4 CUL7 DOCK5 TCF7L2 TMEM39B MYOF BCL11B PRELID3A POFUT1	2.18e-04	197	235	9	2324_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; PC3; HT_HG-U133A	EMC1 AOC1 KIAA0319L KCNAB1 PLA2G6 HIF3A KCTD14 LRP4 FBXO21	2.18e-04	197	235	9	5787_UP
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	ATG2A DOCK5 PARP4 LMF2 MMP19 TCF7 RBM5 LSS SMPD1	2.18e-04	197	235	9	5302_UP
Drug	Ici 216140	GRP CCK EGF	2.23e-04	12	235	3	CID005487263
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A	EMC1 TNFRSF10B DENND2B DOCK5 LMF2 FAM168A TBCD PITPNM1 POFUT1	2.26e-04	198	235	9	3356_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A	ANKMY1 PEX5 KCNN4 PLA2G6 IPO5 POLG PRELID3A LSS GREB1	2.26e-04	198	235	9	6046_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A	TNFRSF10B CUL7 F5 TCF7L2 HIF3A ANO10 ELMO3 FAM222B RBM5	2.26e-04	198	235	9	2381_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ANKMY1 CUL7 ABCA7 DOCK5 GYG2 TBCD FKRP RHOBTB3 SMPD1	2.26e-04	198	235	9	4367_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A	FBXL5 FBXO38 LMF2 DLC1 SUPT6H KCNN4 PLA2G6 ICA1 POFUT1	2.26e-04	198	235	9	6263_UP
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DENND4A CUL7 PCNX2 JAG2 PEX5 GYG2 PLA2G6 DGCR8 BCL11B	2.26e-04	198	235	9	5452_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A	ACACB ANKMY1 TNFRSF10B MAP3K12 FAM168A SUPT6H TCF7L2 RHOBTB3 GLCE	2.26e-04	198	235	9	5885_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	EMC1 ANKMY1 TNFRSF10B PEX5 GYG2 IPO5 SEMA4F POFUT1 ZC3HAV1	2.26e-04	198	235	9	4788_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ANKMY1 CUL7 FBXO38 PLA2G6 LRP5L MMP19 TCF7 TCF7L2 POFUT1	2.26e-04	198	235	9	2316_DN
Drug	Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	DPF1 KIAA0319L ITGA7 F5 CHRNB3 PLA2G6 ACSS3 ICA1 LSS	2.26e-04	198	235	9	4584_UP
Drug	Bacitracin [1405-87-4]; Down 200; 2.8uM; HL60; HT_HG-U133A	PCNX2 LMF2 DLC1 TBCD TCF7 RHOBTB3 ICA1 SMPD1 SMPD2	2.26e-04	198	235	9	3109_DN
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	ANKMY1 MAP3K12 ABCA7 DENND2B PEX5 DGCR8 BCL11B EPHA2 SLC29A1	2.35e-04	199	235	9	7496_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	EMC1 JAK2 TAS2R9 IPO5 POLG ICA1 RBM5 POFUT1 FBXO21	2.35e-04	199	235	9	5543_UP
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	DOCK4 ABCA7 JAK2 UGT8 GYG2 MMP10 ICA1 BCL11B FBXO21	2.35e-04	199	235	9	3169_UP
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; HL60; HT_HG-U133A	MAP3K12 ABCA7 DLC1 ENC1 TMEM39B PIGV PTPA GLCE RBM5	2.35e-04	199	235	9	2487_DN
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	KIAA0319L TNFRSF10B PEX5 KCNAB1 GYG2 TCF7L2 PITPNM1 MYOF LSS	2.35e-04	199	235	9	2243_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	CUL7 DLC1 SUPT6H GYG2 NDUFAF5 ICA1 HIF3A ADGB DNAI2	2.35e-04	199	235	9	4995_UP
Drug	Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; HL60; HT_HG-U133A	KIAA0319L CUL7 DLC1 KCNAB1 TCF7L2 ENC1 ADGB SMPD2 LEF1	2.35e-04	199	235	9	3059_DN
Drug	Butacaine [149-16-6]; Up 200; 13uM; PC3; HT_HG-U133A	DLC1 KCNAB1 ACSS3 SEMA4F RHOBTB3 DOCK10 RNF17 PRELID3A POFUT1	2.35e-04	199	235	9	5748_UP
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; HL60; HT_HG-U133A	CUL7 LMF2 PLA2G6 DGCR8 TCF7L2 MYOF FAM222B LSS ZC3HAV1	2.35e-04	199	235	9	1277_DN
Drug	sulfamate	NPIPA1 KCNN4 PLA2G6 CA13 KY	2.35e-04	54	235	5	CID000005987
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A	EMC1 KLHL9 LMF2 PACS2 KCNAB1 ANGEL1 ANO10 CPT1A MYOF	2.44e-04	200	235	9	3078_DN
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A	ACACB DOCK5 IPO5 TCF7L2 MYOF PTPA EGF MTOR POFUT1	2.44e-04	200	235	9	6298_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	HIC1 CDS2 MAP3K12 TBC1D9 DLC1 KCNAB1 CPT1A SMPD2 LEF1	2.44e-04	200	235	9	3081_UP
Disease	Seizures	PNKP PACS2 GNB1 TBCD CACNA1B FKRP POLG POMC CCK MTR LSS	1.44e-06	218	233	11	C0036572
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB FZD9 DNAH10 APOA5 CPT1A TGDS DOCK7	2.20e-05	106	233	7	EFO_0008317, EFO_0008596
Disease	triglyceride measurement, phospholipid measurement	ACACB TNFRSF10B FZD9 PLA2G6 DNAH10 APOA5 TGDS DOCK7	2.22e-05	146	233	8	EFO_0004530, EFO_0004639
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB FZD9 DNAH10 APOA5 CPT1A TGDS DOCK7	2.79e-05	110	233	7	EFO_0008317, EFO_0008591, EFO_0008596
Disease	Hepatic Vein Thrombosis	F5 JAK2	6.21e-05	2	233	2	C0019154
Disease	Budd-Chiari syndrome	F5 JAK2	6.21e-05	2	233	2	cv:C0856761
Disease	BUDD-CHIARI SYNDROME	F5 JAK2	6.21e-05	2	233	2	600880
Disease	Budd-Chiari Syndrome	F5 JAK2	6.21e-05	2	233	2	C0856761
Disease	cerebral infarction (is_implicated_in)	F5 KCNN4 APOA5 AGXT2	7.71e-05	29	233	4	DOID:3526 (is_implicated_in)
Disease	Severe Congenital Microcephaly	PNKP DYNC1H1 TBCD TSEN2	1.01e-04	31	233	4	C3853041
Disease	Gastrointestinal Diseases	POMC CCK MTR	1.01e-04	12	233	3	C0017178
Disease	Functional Gastrointestinal Disorders	POMC CCK MTR	1.01e-04	12	233	3	C0559031
Disease	Cholera Infantum	POMC CCK MTR	1.01e-04	12	233	3	C1565321
Disease	Microlissencephaly	PNKP DYNC1H1 TBCD TSEN2	1.30e-04	33	233	4	C1956147
Disease	Malformations of Cortical Development	DYNC1H1 TBCD MTOR	1.66e-04	14	233	3	C1955869
Disease	Cortical Dysplasia	DYNC1H1 TBCD MTOR	1.66e-04	14	233	3	C0431380
Disease	Seizures, Focal	PNKP DYNC1H1 TBCD POLG POMC CCK	1.81e-04	104	233	6	C0751495
Disease	Budd-Chiari syndrome (is_implicated_in)	F5 JAK2	1.85e-04	3	233	2	DOID:11512 (is_implicated_in)
Disease	Microcephaly	PNKP DYNC1H1 TBCD TSEN2 LSS	1.91e-04	67	233	5	C0025958
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ACACB FZD9 PLA2G6 DNAH10 APOA5 CPT1A TGDS DOCK7	2.02e-04	200	233	8	EFO_0004611, EFO_0020945
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	ACACB DNAH10 APOA5 CPT1A TGDS DOCK7	2.46e-04	110	233	6	EFO_0004574, EFO_0008317, EFO_0008596
Disease	Malignant tumor of colon	ITGA7 F5 PARP4 RAD54B TCF7L2 MTOR LEF1	2.82e-04	159	233	7	C0007102
Disease	obesity (implicated_via_orthology)	MKKS TCF7 TCF7L2 DNAH10 POMC AOC3 LEF1 GABRA6	3.28e-04	215	233	8	DOID:9970 (implicated_via_orthology)
Disease	craniosynostosis (implicated_via_orthology)	NELL1 CYP26B1	3.69e-04	4	233	2	DOID:2340 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	ACACB TNFRSF10B FZD9 MGAT5 DNAH10 APOA5 TGDS DOCK7	3.83e-04	220	233	8	EFO_0004529, EFO_0008317
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	ACACB TNFRSF10B FZD9 PLA2G6 DNAH10 APOA5 TGDS DOCK7	4.31e-04	224	233	8	EFO_0004530, EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	ACACB TNFRSF10B MGAT5 DNAH10 APOA5 HIF3A TGDS DOCK7	4.99e-04	229	233	8	EFO_0004639, EFO_0008317
Disease	Deep Vein Thrombosis	F5 F8 JAK2	5.82e-04	21	233	3	C0149871
Disease	Venous Thrombosis	F5 F8 JAK2	5.82e-04	21	233	3	C0042487
Disease	2'-O-methyluridine measurement	PTPA NUP188	6.11e-04	5	233	2	EFO_0800636
Disease	Intellectual Disability	PACS2 GNB1 DYNC1H1 TBCD CNDP1 CACNA1B TCN2 TSEN2 BCL11B MTOR LSS	9.19e-04	447	233	11	C3714756
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 APOA5 CPT1A TGDS DOCK7	9.57e-04	95	233	5	EFO_0004529, EFO_0008317, EFO_0008596
Disease	very low density lipoprotein cholesterol measurement	ACACB TNFRSF10B MGAT5 DNAH10 APOA5 HIF3A TGDS DOCK7	1.14e-03	260	233	8	EFO_0008317
Disease	Generalized seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0234533
Disease	Clonic Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0234535
Disease	Non-epileptic convulsion	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0751056
Disease	Atonic Absence Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0751123
Disease	Single Seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0751110
Disease	Visual seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0270824
Disease	Epileptic drop attack	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0270846
Disease	Vertiginous seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0422855
Disease	Gustatory seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0422854
Disease	Seizures, Somatosensory	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0422850
Disease	Olfactory seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0422853
Disease	Seizures, Auditory	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0422852
Disease	Convulsive Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0751494
Disease	Seizures, Sensory	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0751496
Disease	Complex partial seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0149958
Disease	Nonepileptic Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C3495874
Disease	Generalized Absence Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C4505436
Disease	Jacksonian Seizure	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C0022333
Disease	Epileptic Seizures	PNKP TBCD POLG POMC CCK	1.26e-03	101	233	5	C4317109
Disease	brain edema (is_marker_for)	KCNN4 CACNA1B	1.27e-03	7	233	2	DOID:4724 (is_marker_for)
Disease	Polysyndactyly	JAG2 LRP4	1.27e-03	7	233	2	C0265553
Disease	neuropilin-1 measurement	NELL1 DOCK7	1.27e-03	7	233	2	EFO_0020603
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	ACACB FZD9 PLA2G6 DNAH10 APOA5 CPT1A DOCK7	1.31e-03	206	233	7	EFO_0004612, EFO_0020947
Disease	Absence Seizures	PNKP TBCD POLG POMC CCK	1.32e-03	102	233	5	C4316903
Disease	Convulsions	PNKP TBCD POLG POMC CCK	1.32e-03	102	233	5	C4048158
Disease	Tonic Seizures	PNKP TBCD POLG POMC CCK	1.32e-03	102	233	5	C0270844
Disease	Weight Gain	IDO1 POMC SLU7 TSEN2 FBXO21	1.32e-03	102	233	5	C0043094
Disease	Colonic Neoplasms	ITGA7 F5 PARP4 TCF7L2 MTOR LEF1	1.35e-03	152	233	6	C0009375
Disease	Tonic - clonic seizures	PNKP TBCD POLG POMC CCK	1.43e-03	104	233	5	C0494475
Disease	Myoclonic Seizures	PNKP TBCD POLG POMC CCK	1.43e-03	104	233	5	C4317123
Disease	Colorectal Carcinoma	SYT9 F5 NELL1 GDAP1L1 DLC1 DNAH3 TCF7L2 TCN2 CAPN6 LIFR BCL11B LEF1 SLC29A1 GABRA6	1.48e-03	702	233	14	C0009402
Disease	glutamate measurement	NDUFB6 DGLUCY RHOBTB3	1.53e-03	29	233	3	EFO_0010487
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	ACACB MGAT5 DNAH10 APOA5 HIF3A TGDS DOCK7	1.67e-03	215	233	7	EFO_0008317, EFO_0008591
Disease	Syndactyly	JAG2 LRP4	1.68e-03	8	233	2	C0039075
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	FZD9 APOA5 CPT1A TGDS DOCK7	1.77e-03	109	233	5	EFO_0004639, EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB DNAH10 APOA5 TGDS DOCK7	1.84e-03	110	233	5	EFO_0008317, EFO_0008596, EFO_0010351
Disease	Diabetes Mellitus	POMC CPT1A AOC3	2.04e-03	32	233	3	C0011849
Disease	temporal lobe epilepsy (implicated_via_orthology)	KCNN4 MTOR	2.15e-03	9	233	2	DOID:3328 (implicated_via_orthology)
Disease	symmetrical dimethylarginine measurement	NELL1 AGXT2	2.15e-03	9	233	2	EFO_0006523
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB NPIPA1 SPDEF PLA2G6 DNAH10 APOA5 CPT1A DOCK7	2.30e-03	291	233	8	EFO_0008317, EFO_0020946
Disease	glycoprotein measurement	ADGRV1 TNFRSF10B ARHGAP21 APOA5 DOCK7	2.59e-03	119	233	5	EFO_0004555
Disease	morbid obesity (is_marker_for)	AQP7 CCK	2.68e-03	10	233	2	DOID:11981 (is_marker_for)
Disease	Leukoencephalopathy	TCN2 MTR	3.26e-03	11	233	2	C0270612
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	ACACB PLA2G6 DNAH10 APOA5 CPT1A TGDS DOCK7	3.31e-03	243	233	7	EFO_0004612, EFO_0020944
Disease	urinary metabolite measurement	AOC1 UBTFL1 FBXL5 DGLUCY AGXT2 PTPA STON2	3.46e-03	245	233	7	EFO_0005116
Disease	colon cancer (biomarker_via_orthology)	TNFRSF10B JAK2 MTOR	3.60e-03	39	233	3	DOID:219 (biomarker_via_orthology)
Disease	metabolite measurement, body weight gain	PEX5 DNAI2	3.89e-03	12	233	2	EFO_0004566, EFO_0004725
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	APOA5 DOCK7	3.89e-03	12	233	2	OBA_2045152
Disease	Mental Disorders, Severe	DGCR8 POMC	3.89e-03	12	233	2	C4046029
Disease	Diagnosis, Psychiatric	DGCR8 POMC	3.89e-03	12	233	2	C0376338
Disease	Behavior Disorders	DGCR8 POMC	3.89e-03	12	233	2	C0004930
Disease	Mental disorders	DGCR8 POMC	3.89e-03	12	233	2	C0004936
Disease	Congenital muscular dystrophy	ITGA7 FKRP	3.89e-03	12	233	2	cv:C0699743
Disease	Thromboembolism	F5 JAK2	3.89e-03	12	233	2	C0040038
Disease	Hypertensive disease	AOC1 SLC6A18 POMC GJC1 MTOR AOC3	4.11e-03	190	233	6	C0020538
Disease	clinical treatment	TCF7L2 APOA5 ICA1	4.15e-03	41	233	3	EFO_0007056
Disease	very low density lipoprotein particle size measurement	TNFRSF10B FZD9 APOA5 TGDS DOCK7	4.17e-03	133	233	5	EFO_0008594
Disease	type 2 diabetes mellitus (is_marker_for)	F8 TCF7L2 APOA5 AQP7 AOC3	4.58e-03	136	233	5	DOID:9352 (is_marker_for)
Disease	Schizophrenia	DOCK4 JAG2 PLA2G6 DGCR8 GRIN3A IPO5 CACNA1B TCF7L2 CCK PITPNM1 LIFR MTOR STON2 MTR GABRA6	4.65e-03	883	233	15	C0036341
Disease	spleen volume	HIC1 SMIM29 EGF	4.75e-03	43	233	3	EFO_0600047
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ACACB APOA5 CPT1A DOCK7	4.85e-03	86	233	4	EFO_0008595, EFO_0020945
Disease	Bipolar Disorder	CHRNB3 PLA2G6 GRIN3A MMP10 CACNA1B TCF7L2 POLG POMC PTPA MTR	4.87e-03	477	233	10	C0005586
Disease	cholesteryl ester 20:4 measurement	DGCR8 BEST1 APOA5	5.07e-03	44	233	3	EFO_0010348
Disease	uterine fibroid	DOCK5 NELL1 COG6 KCNAB1 TEX11 GREB1	5.14e-03	199	233	6	EFO_0000731
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TNFRSF10B SPDEF DNAH10 APOA5 CPT1A DOCK7 LRP4	5.18e-03	264	233	7	EFO_0008317, EFO_0020944
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	TCN2 MTR	5.31e-03	14	233	2	C1858991
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	BEST1 DOCK7	5.31e-03	14	233	2	OBA_2045100

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRSLLHWYPSVKRME	TDRD5	966	Q8NAT2
YFQKPLLLHQGHMEW	AGXT2	81	Q9BYV1
TAKTLYMSHRELPAW	ESYT1	116	Q9BSJ8
STYHPMAPWVKRLFL	CHRNB3	326	Q05901
YENNSWSMSLGIKHP	CATSPERD	121	Q86XM0
VYGVSPIHDKWEMER	ABL2	271	P42684
VISLHPGYMDKVWEL	ADGB	276	Q8N7X0
LPTAWHNLVYRMRGD	SMPD1	551	P17405
TLKYPMEHGIITNWD	POTEKP	66	Q9BYX7
NCYIWMEKTHRGPGL	DPF1	51	Q92782
SGLNWAEKHCPMARY	B3GALT4	156	O96024
GHVRLWYKTMSGTAE	ADGRV1	4296	Q8WXG9
GWKTVRMYPFQIHSI	CDS2	326	O95674
WLYHDGRLLKPREME	CPT1A	346	P50416
RLQPYMAEAHELVGW	APOA5	106	Q6Q788
MLGIAPNLARWDYHT	GLCE	566	O94923
ADHPNRTPSIWLAMY	ABCC9	276	O60706
TLKDHMDPYWALENR	BEST1	566	O76090
MSRLSWGYREHNGPI	CA13	1	Q8N1Q1
YLDSHRVEKPRNHWM	CFAP161	251	Q6P656
PWGHKRTYRLQIHSM	AOC1	586	P19801
LDPSHRISDRDYMGW	CCK	86	P06307
PHVKNWGSLLRMYGR	DGCR8	686	Q8WYQ5
HMAYLTDAAWSPVRP	DNAI2	406	Q9GZS0
LHRMWSPQDRKYNSP	DENND2B	526	P78524
GWPMVLKHSVDATYE	CACNA1B	1366	Q00975
KATLRHYMALPEQSW	ATG2A	1071	Q2TAZ0
KHLQLMGGLSPTLYW	ABCA7	1566	Q8IZY2
KWGHPRGYRIQMLSF	AOC3	596	Q16853
AHKIAKRYSSIPQMW	DENND4A	746	Q7Z401
WPYLTAETLKNRMGH	NPIPB3	231	Q92617
MSRVWRDGQKYPVHI	RAD54B	751	Q9Y620
GLVHPFKMKWQYTNR	QRFPR	146	Q96P65
ALMSETERIWYPPNH	JAK2	86	O60674
RHWPGPMSLALYLTD	LARGE2	451	Q8N3Y3
QSEHKEPWFMRLNLG	GDAP1L1	81	Q96MZ0
WPYLTAETLKNRMGH	NPIPA1	231	Q9UND3
WPYLTAETLKNRMGH	NPIPB12	231	F8W0I5
RQLHMQLYPGWSARD	LEF1	356	Q9UJU2
ILEWLSYMPKDNHSP	ACACB	2006	O00763
IMESFLPYWLQRKHG	ANO10	446	Q9NW15
ALWHGIYMPKEKRAR	ANKAR	156	Q7Z5J8
YTLSEKRGWMPIHFA	ANKAR	596	Q7Z5J8
YAPSKRWHIDTIMRV	AP1G1	411	O43747
SFPGMPKWRKTHLTY	MMP10	101	P09238
QFRVRWPSLMKHYSP	FBXO21	76	O94952
KMPWIEYNHEKVSGT	FAXC	146	Q5TGI0
TLKYPMEHGIITNWD	POTEF	766	A5A3E0
WHMKPQSRAYRFTGH	POC1A	46	Q8NBT0
LHYAAWQGRKEPMKL	CASKIN1	86	Q8WXD9
SVYGLKMQWTPEHAQ	FIGN	6	Q5HY92
YNDWMFIAKHLPDLI	IDO1	36	P14902
HYMDWVRQAPGKGLE	IGHV3-72	51	A0A0B4J1Y9
DMKYGHLWSVQADSP	MKKS	471	Q9NPJ1
YAMHWVRQAPGKGLE	IGHV3-43D	51	P0DP04
SYAMHWVRQAPGKGL	IGHV3-64	51	A0A075B6Q5
HSAYATLLMKQAWPQ	FAM168A	56	Q92567
GWRSAFKEVSLPMAH	KIAA0825	416	Q8IV33
RHWFVAKLYMNTHPG	KCNN4	191	O15554
PDIMHYALLGLRKWS	GREB1	1686	Q4ZG55
KTLGPSWVHYQCMLR	MGAT5	361	Q09328
WVSMSYPALHQKTLR	WWC1	731	Q8IX03
SLLYRWMKHEPGLGS	HIC1	326	Q14526
YAMHWVRQAPGKGLE	IGHV3-30-3	51	P0DP02
WQLITHPRDYSGEME	KIAA0319L	346	Q8IZA0
MINPEDRWKSLHFSG	JAG2	171	Q9Y219
LPELYHKIGVGAMTW	KCNAB1	281	Q14722
DAHAYPWDRSSLKSM	KY	131	Q8NBH2
YLPDHMTLWRGFLNE	AQP7P3	161	A6NL99
YLPDHMTLWRGFLNE	AQP7B	166	A0A075B734
IPKGWSVMYSIRDTH	CYP26B1	386	Q9NR63
YAMHWVRQAPGKGLE	IGHV3-9	51	P01782
KHRVVTCMDWSLQYP	DYNC1I1	286	O14576
QPFAKWHYIERDLAM	PCNX2	1561	A6NKB5
RVEKGYPRNISHNWM	MMP19	456	Q99542
DLPSREARQAMIYHW	KATNAL2	421	Q8IYT4
EARQAMIYHWLPPVS	KATNAL2	426	Q8IYT4
PKHMEAWQYLGTTQA	PEX5	366	P50542
LENKSPWRKMVHGVY	NDUFB6	51	O95139
LMHMLSSPDYQIRWS	CUL7	166	Q14999
QKWDTTQKMRTAHYP	FAM222B	26	Q8WU58
GTVLTKMYPRGNHWA	GRP	31	P07492
HVSRIPDYLWMGLDG	LSS	361	P48449
KRSYSMEHFRWGKPV	POMC	136	P01189
KLMALTWDGFPLHYS	POLG	601	P54098
EWRSLAPMDAPRYQH	KLHL9	326	Q9P2J3
HPIFRNGDYPDTMKW	LCT	1156	P09848
AIALHPEMGLTYWID	LRP5L	81	A4QPB2
WPYLTAETLKNRMGH	NPIPB5	231	A8MRT5
AKIYAMHWGTDSRLL	GNB2	56	P62879
RHSLPKVSYATAMDW	GABRA6	291	Q16445
YAMHWVRQAPGKGLE	IGHV3-64D	51	A0A0J9YX35
AWPKMHTVNGYVNRS	F8	246	P00451
YLPDHMTLWRGFLNE	AQP7	161	O14520
WPYLTAETLKNRMGH	NPIPA3	231	F8WFD2
LHIGLSAAYLPRMWV	PARP4	831	Q9UKK3
LSHKTPDWLGYMRFL	PACS2	571	Q86VP3
MLQNPDWKYRHAGLM	IPO5	366	O00410
DWKYRHAGLMALSAI	IPO5	371	O00410
TVDRMSHVLWPYLLQ	MROH1	476	Q8NDA8
VPYNRHLAEVWRMLS	MROH8	431	Q9H579
WPYLTAETLKNRMGH	NPIPB4	231	C9JG80
IAMHYSNPRPKFEDW	RBM5	171	P52756
HSVMLKSGTNILYWR	ELAPOR2	246	A8MWY0
RTEALPYRMADGQWH	NELL1	136	Q92832
PYRMADGQWHKVALS	NELL1	141	Q92832
YTMHWVRQAPGKGLE	IGHV3-43	51	A0A0B4J1X8
HGSWMKDAVYNSPKV	OLFML1	161	Q6UWY5
MDYGIWPEQAQRHKT	GRIN3A	491	Q8TCU5
WPYLTAETLKNRMGH	NPIPB11	231	E5RHQ5
CWGIPYLSKHRADRM	SMPD2	16	O60906
TLKYPMEHGIITNWD	POTEE	766	Q6S8J3
WTYMPHVHILGKFRN	FBXO38	156	Q6PIJ6
AKVVHFLGSMKPWNY	GYG2	241	O15488
SHDPLRYVGDMLAWL	COG6	301	Q9Y2V7
SYFHMAAWGLPALKT	FZD9	356	O00144
ILGHPYDVAIDMWSL	DYRK4	276	Q9NR20
YILWSKCMHDTSGPV	FHIP1A	461	Q05DH4
KWEIVGNLPSAMRSH	KLHL23	536	Q8NBE8
WLVGYAASRHFMKDP	BCL11B	711	Q9C0K0
SVGYAWLPLMKHDQI	DOCK10	786	Q96BY6
WLPLMKHDQIASQEY	DOCK10	791	Q96BY6
LTYPMQTEWQRKEHL	DOCK4	1241	Q8N1I0
RIRDMWYNLGPHKIK	DOCK5	1086	Q9H7D0
LGKYRMPFAWTAIHL	DOCK7	391	Q96N67
GKMYVHRQVRPEAWL	CD1C	196	P29017
HQLGWKPLKDSYMDT	DNAH3	1856	Q8TD57
MLQWSKDIRSPEQHY	GCNT7	301	Q6ZNI0
AKIYAMHWGTDSRLL	GNB1	56	P62873
HPMAKRLFWTDTGIN	EGF	606	P01133
PYAMRWKQHRALEET	GJC1	116	P36383
MKLFPHSQLFRQWGE	GALNT8	116	Q9NY28
DMLAKTHPYNPLWAQ	FNIP1	491	Q8TF40
SVNMLAKTHPYNPLW	FNIP2	471	Q9P278
RPYWELSNHEVMKAI	EPHA2	816	P29317
LACAPLYHWRTEMKQ	ITGAV	136	P06756
PEKSMYDLVHGSSLW	UGT8	226	Q16880
TPWILDLLGHYAVMN	ILF2	241	Q12905
IRYPMEHGIVKDWND	ACTR1A	71	P61163
YKFRNKPAHTSWNMG	ANKMY1	226	Q9P2S6
TEEYRHMPLLKLWVG	CYP4V2	81	Q6ZWL3
IPKGWSVMYSIRDTH	CYP26C1	401	Q6V0L0
GASPVERKHMLDYLW	ELMO3	241	Q96BJ8
RPVWTMIGKAYSTEH	MAP3K12	96	Q12852
HSYSNLPIWVNKLDM	DYNC1H1	891	Q14204
KEHLWMYLQALGFEP	HAUS6	11	Q7Z4H7
KPLSGIRYMWSYHLI	SLC44A3	371	Q8N4M1
HEIANGKWLLYPMQV	ITGA7	911	Q13683
RWYHAQMPDSLRSGE	AHCTF1	406	Q8WYP5
HYDPTINKWTMVAPL	ENC1	416	O14682
HLWKMFYDARKPRSQ	EMC1	501	Q8N766
FTAPHWRMKQLVGLY	FBXL5	11	Q9UKA1
YPRNGVMTKDTWLDH	FKRP	421	Q9H9S5
AISETRMGHPQFWKY	DGLUCY	81	Q7Z3D6
WGLLKGHTYTMTDIR	CAPN6	246	Q9Y6Q1
DHMVRWYLAIGPLLT	DNAH10	826	Q8IVF4
PWMKKIHVSAVNPSY	HOXA4	196	Q00056
YIQTLKDHRPRMVWD	CHID1	321	Q9BWS9
FLPGWNLIYTMQKHL	DHX9	656	Q08211
ALQFIKQYWKMHGRP	PHKB	601	Q93100
KGILLTWHYDPNMTC	LIFR	641	P42702
WPYLTAETLKNRMGH	NPIPB13	231	A6NJU9
KPLHYMTIISQWVCG	OR4C16	126	Q8NGL9
EKHRWPSNMYLKQLA	RHOBTB3	581	O94955
MSGHKCSYPWDLQDR	ICA1	1	Q05084
VLEEHRPLQKYMVWS	POFUT1	201	Q9H488
HYPTLMSWQVCGKLA	OR10R2	151	Q8NGX6
PHEDMRTWLKYASLC	MTOR	1646	P42345
WPYLTAETLKNRMGH	NPIPA7	231	E9PJI5
WPYLTAETLKNRMGH	NPIPA8	231	P0DM63
GRDHWSEMLSYPRKP	SYT9	466	Q86SS6
MPIITSKRYQHSVEW	TSEN2	96	Q8NCE0
IPWMGDHKILIDRYD	SFSWAP	61	Q12872
LATYPKSGTTWMHEI	SULT1C3	51	Q6IMI6
PVENMKLYHSWLLVG	SEMA4F	486	O95754
SVMQKIIPHYSLARW	TMEM161B	16	Q8NDZ6
PGLKMYEQEWVRLHL	F5	1816	P12259
HHWTEIEFMYKPGNL	LMF2	476	Q9BU23
WPYLTAETLKNRMGH	NPIPA5	231	E9PKD4
QLTNPYGSWRMHTKI	MRPL45	251	Q9BRJ2
LAFYWILKAGHMVPS	SCPEP1	421	Q9HB40
LPKAAMITHQRIWYG	SLC27A2	231	O14975
MIKLVPHNESAWNYL	FNTA	266	P49354
WKVLNCSGHMRAYKP	HIF3A	186	Q9Y2N7
GYPSQPDHTEKLTMW	MTR	1176	Q99707
GHPWDTVIQAAMRKY	PRELID3A	11	Q96N28
SRKHRYPQSMWEPEG	RUFY4	256	Q6ZNE9
KHSYMWSLSIGALIG	SHISAL2B	56	A6NKW6
WQSGYQHKRMPLLDV	SMIM29	86	Q86T20
TLKYPMEHGIITNWD	POTEI	766	P0CG38
GLYRKPVTGMWDHLQ	PNKP	256	Q96T60
YGASPLHWAKNAEMA	PLA2G6	286	O60733
FGPWKAVLDNSDLMH	KCTD14	201	Q9BQ13
LRTYKNSMQGHGTWL	PLB1	701	Q6P1J6
MIGWKYHESQARPAE	NDUFAF5	306	Q5TEU4
VDLRGHMPEWYTKSF	DLC1	1486	Q96QB1
QSPDWKYRHAGLMAL	RANBP6	376	O60518
MKEYGPIHILWSASE	SNX7	221	Q9UNH6
MTTSHQPQDRYKAVW	SLC29A1	1	Q99808
MYGLETCPNTWLRAH	SLC36A3	116	Q495N2
MSSRHWGPIFVKLTD	STON2	441	Q8WXE9
YPAVLMHLNATWPKR	SLC6A18	346	Q96N87
WMDRLSLEHLNPSIY	TCN2	41	P20062
NKHSPSTRWFVEGML	ACSS3	96	Q9H6R3
IRDGELQYHGMPAWK	ANGEL1	446	Q9UNK9
QSELHYANLELLMWP	CD300A	226	Q9UGN4
KNMHWYSPPERTESF	CLDND1	86	Q9NY35
FDTKEEILMHLWRYP	CNDP1	331	Q96KN2
YHKEERVWITRAPGM	CNOT2	471	Q9NZN8
IMLLHWKASYNGGKS	PROKR1	356	Q8TCW9
PWEKLSIHLYFDGMS	RNF17	1331	Q9BXT8
RNPIMGLLYHWKTCS	PIGV	451	Q9NUD9
SRVHPETYEWARKMA	SUPT6H	1056	Q7KZ85
RYPMKSEKIHGLGWR	TGDS	301	O95455
VYIMTQPLSGKWIHF	PITPNM1	956	O00562
DINGKMWLRNPCHLY	RNF213	2081	Q63HN8
WICMGSLSRANPYKH	RNF14	431	Q9UBS8
WGSVIYPSMKKAIAH	TTLL8	491	A6PVC2
SFPWVASRMHYGRKQ	nan	26	Q8N2B8
MPHNKGTRFSEAWEY	ZBED2	46	Q9BTP6
RFLTKMWHPNIYETG	CDC34	76	P49427
MQPQPLETSHKYESW	ZSCAN21	161	Q9Y5A6
MALPRSQGHWSNKDI	UBTFL1	1	P0CB47
HMDPDKLNGLWSRIS	TOR1AIP1	551	Q5JTV8
GTYHFLRTQKIIWMP	STYXL1	136	Q9Y6J8
RPGMEYTVHVWAQKG	TNN	856	Q9UQP3
PVLYKWNSKARMTAH	TIGD1	256	Q96MW7
SLIISVPKNDDMWYH	TAS2R9	141	Q9NYW1
HTVPDMGKWKRSQAY	PTPA	31	Q15257
WTEHQYRLPPMGKAF	SPDEF	161	O95238
SSLLGARLYWMGNKP	TMTC2	236	Q8N394
EAYMRLSKLPEAEHW	TMTC2	651	Q8N394
SMYKRLGVSAWLNHL	TBC1D16	391	Q8TBP0
ERQLHMQLYPGWSAR	TCF7L2	406	Q9NQB0
GKVPRQGWMYLSINH	TBC1D9	171	Q6ZT07
YQHWLPKILGEVGMR	PXDN	1031	Q92626
EGWRDSHQPIMCSYK	PITPNC1	171	Q9UKF7
WYRQNTGMGPKHLLS	TRAV7	56	A0A075B6U4
LHQLWRQYMTLPAKA	MYCBPAP	611	Q8TBZ2
YKTEAPTWETHGNLM	NUP188	181	Q5SRE5
HISRTKDYPEMEILW	TEX11	851	Q8IYF3
KRDRWNGYNPEEHMK	SLU7	166	O95391
AGHRDTLYTMLIKWV	TNFRSF10B	376	O14763
YHPSNNGRWLNKLMK	PSME4	341	Q14997
RQLHMQLYPGWSARD	TCF7	326	P36402
WPYLTAETLKNRMGH	NPIPB2	246	A6NJ64
KYISPQHWESLMNGP	ZNFX1	751	Q9P2E3
WYLVRHQRVHTGMKP	ZNF550	216	Q7Z398
PKDHEAWETRYMLLL	TBCD	141	Q9BTW9
RFLTKMWHPNIYENG	UBE2R2	76	Q712K3
HFHLPYRWQMLIGKT	ZC3HAV1	531	Q7Z2W4
FSAKDYMARTPHWAL	TYW1	691	Q9NV66
RPWKQMYVVLRGHSL	ARHGAP21	956	Q5T5U3
MVRVAGHPNVYKSSW	TMEM236	251	Q5W0B7
WKQHTRQLYGPDAMP	TMEM39B	246	Q9GZU3
PRAIALHPMEGTIYW	LRP4	556	O75096
FVYDEPGHAVMRKWL	MYOF	286	Q9NZM1